Get started
Author

Zoë S. Walters

Observed names: Walters, Zoë S, Walters, Zoë S., Z S Walters, Z Walters, Zoe S Walters, Zoe S. Walters, Zoe Walters, Zoë S Walters, Zoë Walters
Observed institutions: University of Parma, Institute of Cancer Research, Cancer Research UK, Southampton General Hospital, Amsterdam UMC Location University of Amsterdam, University Hospital Southampton NHS Foundation Trust, Institute of Cancer Research, University of Southampton, Cardiff University, University of Amsterdam, University of Bologna
ORCID: 0000-0002-1835-5868
Observed ORCID: 0000-0002-1835-5868
OpenAlex ID: A5007982296
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
2017 · C Pawlyn, M D Bright, et al. · Blood Cancer Journal · 109
PDF
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
2013 · Z S Walters, B Villarejo-Balcells, et al. · Oncogene · 102
PDF
8-Substituted Pyrido[3,4- d ]pyrimidin-4(3 H )-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors
2016 · Vassilios Bavetsias, Rachel M. Lanigan, et al. · Journal of Medicinal Chemistry · 96
PDF
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
2011 · Roberto Tonelli, Alan McIntyre, et al. · Clinical Cancer Research · 91
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)
2013 · R Ciarapica, M De Salvo, et al. · Oncogene · 69
PDF
Epigenetic Targets in Synovial Sarcoma: A Mini-Review
2019 · Ryland Hale, Sami Sandakly, et al. · Frontiers in Oncology · 44
PDF
The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review
2023 · Nora Wangari Murage, Nada Mabrouk Ahmed, et al. · Cancer and Metastasis Reviews · 30
PDF
Review: Targeting EZH2 in neuroblastoma
2023 · Jinhui Gao, Claire Fosbrook, et al. · Cancer Treatment Reviews · 29
PDF
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
2018 · Eleanor M. O’Brien, Joanna L. Selfe, et al. · BMC Cancer · 29
PDF
MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas
2016 · Edoardo Missiaglia, Chris J. Shepherd, et al. · Cancer Letters · 28
PDF
Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma
2024 · Benjamin P. Sharpe, Liliya A. Nazlamova, et al. · Cell Reports Methods · 25
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
2023 · Silvia Pomella, Matteo Cassandri, et al. · Nature Communications · 25
PDF
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
2022 · Benjamin P. Sharpe, Annette Hayden, et al. · Cell Reports Medicine · 24
PDF
FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
2021 · Christopher I. Milton, Joanna Selfe, et al. · Molecular Oncology · 19
PDF
Pathogenic KDM5B variants in the context of developmental disorders
2022 · Jack Harrington, Gabrielle Wheway, et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 18
PDF
Machine learning to predict curative multidisciplinary team treatment decisions in oesophageal cancer
2023 · Navamayooran Thavanesan, Indu Bodala, et al. · European Journal of Surgical Oncology · 16
PDF
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
2023 · Silvia Pomella, Sara G. Danielli, et al. · Cancers · 13
PDF
Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
2021 · Zoë S. Walters, Ewa Aladowicz, et al. · Cancers · 11
PDF
NKCC1 (SLC12a2) induces a secondary axis in Xenopus laevis embryos independently of its co‐transporter function
2008 · Zoë S. Walters, Kim E. Haworth, et al. · The Journal of Physiology · 11
Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
2021 · Fereshteh Izadi, Benjamin P. Sharpe, et al. · Cancers · 9
PDF
Insights from explainable AI in oesophageal cancer team decisions
2024 · Navamayooran Thavanesan, Arya Farahi, et al. · Computers in Biology and Medicine · 8
Targeting EZH2 for the treatment of soft tissue sarcomas
2021 · Magdalena Karolak, Ian Tracy, et al. · Journal of Cancer Metastasis and Treatment · 8
PDF
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
2023 · Eleanor O’Brien, Carmen Tse, et al. · Clinical Epigenetics · 6
PDF
Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinoma
2025 · Robert C. Walker, Stella P. Breininger, et al. · British Journal of Cancer · 4
PDF
Patient-Derived Tumor Organoid and Fibroblast Assembloid Models for Interrogation of the Tumor Microenvironment in Esophageal Adenocarcinoma
2024 · Benjamin P. Sharpe, Liliya Nazlamova, et al. · SSRN Electronic Journal · 4
Works count: 87
Citation count: 845
H-index: 16
I10-index: 19
Year
Topic
Type